AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12 | -7.7% | 175 | 0.0% | 0.00% | – |
| Q2 2023 | $13 | +18.2% | 175 | 0.0% | 0.00% | – |
| Q1 2023 | $11 | -15.4% | 175 | 0.0% | 0.00% | – |
| Q4 2022 | $13 | -99.8% | 175 | +35.7% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 129 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | 0.0% | 129 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 129 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | +25.0% | 129 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 129 | +84.3% | 0.00% | – |
| Q2 2021 | $5,000 | +25.0% | 70 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | -33.3% | 70 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | -60.0% | 70 | -66.5% | 0.00% | – |
| Q3 2020 | $15,000 | +36.4% | 209 | +7.2% | 0.00% | – |
| Q2 2020 | $11,000 | 0.0% | 195 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | -45.0% | 195 | 0.0% | 0.00% | – |
| Q4 2019 | $20,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |